Possibility for error in FDA diffusion assays

Area of Science:

• Microbiology
• Pharmaceutical Science
• Analytical Chemistry

Background:

• The US Food and Drug Administration (FDA) single-dose diffusion assay is a standard method for determining antibiotic potency.
• Current computational procedures in this assay may introduce significant errors in potency estimations.
• An unrecognized error in reference solution concentration has been identified as a primary source of inaccuracy.

Purpose of the Study:

• To identify and explain the source of error in the FDA single-dose diffusion assay for antibiotics.
• To propose a correction method to improve the accuracy of antibiotic potency estimation.
• To ensure reliable results in antibiotic susceptibility testing and drug development.

Main Methods:

• Analysis of computational procedures used in the FDA single-dose diffusion assay.
• Identification of the discrepancy in correcting responses from standard and sample plates.
• Development of a revised correction method for assay data.

Main Results:

• A significant error in estimated sample potency arises from differential correction of standard and sample plate responses.
• The error is directly linked to the concentration of the reference solution used.
• A revised method involving consistent correction of both standard and sample responses to the observed reference response eliminates the identified error.

Conclusions:

• The differential correction of responses in the FDA antibiotic diffusion assay leads to substantial errors in potency estimation.
• Correcting both standard and sample responses to the observed reference response is a crucial modification for accurate results.
• Implementing this correction method will enhance the reliability of antibiotic potency assays in pharmaceutical analysis and quality control.